3 ms·

Reminder for this recent Harvard study: http://jamanetwork.com/journals/jama/article-abstract/2545691 http://jamanetwork.com/journals/jama/article-abstract/254

• Angostura 10y ago
  It's really odd. The NHS in the UK does a reasonable job negotiating prices down and recommending generics. It's been recommending an alternative to the Epipen for a while now, I believe. So it shouldn't be intrinsic to state-run medical systems.
  • ceejayoz 10y ago
    It's definitely not intrinsic. "[The] federal government is prohibited from negotiating drug prices on behalf of Medicare Part D plans." http://www.politifact.com/wisconsin/statements/2012/sep/04/tammy-baldwin/uncle-sam-barred-bargaining-medicare-drug-prices-s/ http://www.politifact.com/wisconsin/statements/2012/sep/04/t... It probably doesn't take much guessing to figure out which industry's lobbyists helped that one along.
  • ljf 10y ago
    Yep - we've just been moved off EpiPen to one of the others (I forget which). Interesting is the network effect of EpiPen - many people have been trained to use them and are aware of there exact look and feel. For the new pens they are used in a similar but different way (I think the new ones are actually better/easier) but that might put some people off moving, where they do have a choice (not all doctors are being as strict with moving to the new version).